KIDS
ORTHOPEDIATRICS CORP
NASDAQ · Healthcare · Medical - Devices · US
$22.03
+0.36%Year over year
Reported trailing growth
- Revenue
- +14.5%
- EBITDA
- +65.3%
- EBIT
- +44.8%
- EPS
- +6.1%
- Free cash flow
- +95.1%
- Operating cash flow
- +125.6%
Forward estimates
Based on analyst estimates
- Revenue
- +15.2%
- EBITDA
- +375.7%
- EPS
- +50.6%
Three-year CAGR
- Revenue
- +24.6%
- EBITDA
- +40.3%
- EBIT
- +1.8%
- Net income
- -4.8%
- EPS
- -3.0%
- Free cash flow
- +61.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026